Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.9%

21 terminated/withdrawn out of 303 trials

Success Rate

88.5%

+2.0% vs industry average

Late-Stage Pipeline

14%

43 trials in Phase 3/4

Results Transparency

4%

7 of 162 completed trials have results

Key Signals

43 recruiting7 with results18 terminated

Enrollment Performance

Analytics

N/A
100(52.6%)
Phase 2
36(18.9%)
Phase 3
25(13.2%)
Phase 4
18(9.5%)
Phase 1
10(5.3%)
Early Phase 1
1(0.5%)
190Total
N/A(100)
Phase 2(36)
Phase 3(25)
Phase 4(18)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (303)

Showing 20 of 303 trials
NCT07561645Phase 2Not Yet Recruiting

A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung

Role: lead

NCT07561385Not Yet Recruiting

Dresden MDS Registry With an Accompanying Biomaterial Collection

Role: lead

NCT03188874Recruiting

Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)

Role: lead

NCT05668637Recruiting

Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support

Role: lead

NCT07537491Recruiting

KIA-Korekt: Staged Unimodal-to-Multimodal AI Evaluation for Perioperative Risk Prediction in Colorectal Cancer

Role: collaborator

NCT06595602Recruiting

Intelligent Lung Support in the Intensive Care Unit

Role: lead

NCT05470595Phase 2Active Not Recruiting

A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung

Role: lead

NCT05461729Recruiting

TIMELY-PrädiktoR Prospective Study

Role: collaborator

NCT05268432Recruiting

Development, Intraoperative Demonstration and Visualization of Surgical Assistance Functions

Role: lead

NCT05652361Not ApplicableRecruiting

Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery

Role: lead

NCT06126601Recruiting

Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

Role: lead

NCT07378202Active Not Recruiting

Machine Learning for Prediction of Therapy Response in Autoimmune Hepatitis

Role: collaborator

NCT05843877Phase 3Recruiting

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula

Role: lead

NCT06280755Recruiting

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Role: collaborator

NCT07032246Not ApplicableEnrolling By Invitation

Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study

Role: collaborator

NCT07148193Recruiting

Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

Role: lead

NCT02963025Not ApplicableCompleted

Protective Ventilation With High Versus Low PEEP During One-lung Ventilation for Thoracic Surgery

Role: lead

NCT03396718Not ApplicableRecruiting

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas

Role: lead

NCT06377462Recruiting

Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection

Role: lead

NCT04385290Phase 1Recruiting

Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)

Role: lead